Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. [electronic resource]
Producer: 20000927Description: 794-802 p. digitalISSN:- 0735-1097
- Aged
- Anti-Arrhythmia Agents -- administration & dosage
- Atrial Fibrillation -- drug therapy
- Atrial Flutter -- drug therapy
- Dose-Response Relationship, Drug
- Electrocardiography
- Female
- Heart Rate -- drug effects
- Humans
- Hydantoins
- Imidazoles -- administration & dosage
- Imidazolidines
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.